Navigation Links
Marked improvement in body image, physical stamina, post-surgical pectus patients report
Date:12/1/2008

one of the nation's top researchers on body image issues, to help design a study that would determine whether the trend surgeons noted would hold up to scientific scrutiny.

Other hospitals participating in the study were: All Children's Hospital, St. Petersburg, Fla.; Boston Children's Hospital; Children's Hospital of Wisconsin, Milwaukee, Wisc.; Children's Medical Center, Dallas, Tx.; Children's Mercy Hospital, Kansas City, Mo.; Cincinnati Children's Hospital Medical Center; Hospital for Sick Children, Toronto, Canada; Johns Hopkins University Medical Center, Baltimore, Md; Kapi'olani Medical Center for Women and Children, Honolulu, Hi; and Yale New Haven Children's Hospital.

The survey, which was conducted before and one year after surgery, asked parents how often children with pectus excavatum were irritable, frustrated or depressed and whether they were reluctant to be seen without a shirt or in a bathing suit before surgery.

Patients answered similar questions.

Both patients and parents also answered questions about whether the patient suffered pain or shortness of breath when exercising.

Patients and parents reported striking improvements psychologically and physically.

"One of the most interesting things we discovered was that there was not a direct correlation between the severity of the defect and the degree of improvement in body image," said Kelly. "Even patients with mild deformities experienced significant improvement in body image.

Although the study didn't focus on specific physical activities, it asked both patients and parents how often the pectus excavatum caused pre-surgery patients to have "trouble" exercising and being physically active.

The results showed a stunning improvement, with the physical difficulties score falling between "often" and "very often" before surgery and falling between "sometimes" and "never" after surgery.

Cash also believes the body image
'/>"/>

Contact: Ridgely Ingersoll
Ridgely.Ingersoll@chkd.org
757-472-2893
Children's Hospital of The King's Daughters
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Home Improvement Star Debbe Dunning is New smartTOUCH Spokesperson
2. Nutritionists of the UGR suggest diet improvements during Ramadan
3. Video released of rapid Alzheimers improvement after new immune-based treatment
4. Natural compounds in cocoa tied to blood flow improvements for adults with type 2 diabetes
5. Substantial improvement in essential cheap solar cell process
6. Summer-dormant tall fescue grass shows promise for pasture improvements
7. Physical activity and health: Finding the right prescription
8. Biophysical Society selects 2009 Distinguished Service, Emily M. Gray and Society Fellow recipients
9. UCSB study finds physical strength, fighting ability revealed in human faces
10. Guidelines urge physical activity during pregnancy
11. American Physical Society announces Physics, a new, free, online publication

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)... Lowly bacteria, it turns out, hold the power to h...around the world clean up toxic waste on test site... RDX, were invented back in World War II and have ...e high-energy compounds are often used to propel t... TNT. , But with increased knowledge of their ...
(Date:11/4/2009)...LEY, Calif., Oct. 19 Spectros, dev...ing and imaging devices which shed light on life-t...igned exclusive distribution deals for both its T-...arkets covered include Australia, New Zealand, Th...name, Italy, France, Spain, Portugal, Poland, Gree...
(Date:11/4/2009)...ss., Oct. 20 Aware, Inc.... technology and biometrics software, today reporte...eptember 30, 2009. ,, Michael Tzannes, Aware,...lier today, we announced an agreement to sell our ... new fabless semiconductor company being spun out ...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2Spectros Signs New International Distribution Deals 2Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Award Winning Medical Technology From Germany 5432 1Award Winning Medical Technology From Germany 5432 2Award Winning Medical Technology From Germany 5432 3MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples 5428 1MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples 5428 2U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 1U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 2U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 3
...inked to genetic mutations, stunted growth and dec...rramatta River, the main tributary of Sydney Harbo...nting evidence that toxic sediments and seaweeds i...eatures. , The new findings, published in the jou...enetic mutations among crustaceans ( Melita plumul...
...alcohol syndrome are slight but classic: facial ma...ll eye openings and a short nose. , Researchers w...gure out how much alcohol it takes during what poi...g problems. , They have good evidence that just a... weeks of fetal life, typically before a woman kno...
...chers at the UC Davis M.I.N.D. Institute and The C...rgest study to date describing the medical and psy...der in which males have two "X" and two "Y" chromo...dy, published in the June 15, 2008, issue of the ... offers treatment recommendations for men and boys...
Other Biology News:Heavy metal link to mutations, low growth and fertility among crustaceans in Sydney Harbor tributary 2Alcohol consumption can cause too much cell death, fetal abnormalities 2UC Davis researchers define characteristics, treatment options for XXYY syndrome 2UC Davis researchers define characteristics, treatment options for XXYY syndrome 3
(Date:11/6/2009).... 6 ,, 3Q09 Corpor...enza(TM) E.U. Marketing Authorization to Astellas ...commercial readiness activities Expanded manageme...eting; and Director, Commercial Operations Appoin...udit Committee chairman , Upcoming 2009 Mil...
(Date:11/6/2009)...6 Intarcia Therapeutics, Inc. deli...OS® continuous delivery of exenatide) program... Annual Diabetes Technology Meeting in San Francis...in/prnh/20050301/SFTU126LOGO ) ,, Continuous ...wers Plasma Glucose, HbA1c and Reduces Weight in a...
(Date:11/5/2009).... 5 GenVec, Inc. (Nasdaq...r the third quarter ended September 30, 2009. GenV...share) for the three months ended September 30, 20...er share) in the comparable quarter of 2008. For t...net loss was $14.1 million ($0.15 per share), comp...
(Date:11/5/2009)...ewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bullet...cer, President and CEO of Imagenetix, will be pres...CRO Conference on Thursday, December 3rd, at 10:30...bout LD MICRO ,, LD MICRO is a by-invitation on...lued companies in the micro-cap space. Since 2002,...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...er Provides Extensive Experience In Molecular Diag...h, Inc., a company revolutionizing spine care thro...logies, announced today that Roberto A. Macina, Ph...he company,s new Vice President of Research and De...eth Ward, M.D., Chairman and Chief Scientific Offi...
... Netherlands, February 24 ,Amsterdam Molecular The...f,human gene therapy, today reported its results f...clinical trial in LPL deficiency causes a delay of...GlyberaTM which is now expected H2 2009, - Posi...orijn resigned for personal reasons, - Start of...
...Colo., Feb. 23 The National Academy of Sciences (...ebruary 18, 2009 finds deficiencies in the nation,...rms and new research. The report also calls for t...nes for quality control, proficiency testing, cert...aspects of forensic science. , , The report notes...
Other Biology Technology:Axial Biotech Appoints Dr. Roberto Macina to Vice President of Research and Development 2Amsterdam Molecular Therapeutics Reports Full Year Results 2008 2Amsterdam Molecular Therapeutics Reports Full Year Results 2008 3Strengthening Forensic Toxicology in the United States: The American Board of Forensic Toxicology Response to the National Academy of Sciences Recommendations 2
... with HRP conjugated rabbit polyclonal detection a... coating antibody. • BUF040A contains rab...ding between the coating and detection antibodies....ewly conjugated antibodies, to reconstitute lyophi...
...el piece, we can identify it using MALDI-TOF/TOF m...duce a mixture of peptides. The molecular weights ..., and the amino acid sequences of the top 10 peaks...ALDI-TOF/TOF. The masses and sequences will be use...
OmniSlide Heated Wash Module from Thermo Scientific
Factor Xa Protease from QIAGEN
Biology Products: